.
Sigma Pharmaceutical Limited (ASX:SIP) has generated a first half net profit of $16.3 million despite difficult trading conditions and flat growth in the Pharmaceutical Benefits Scheme.
The result marked a 37 per cent drop in the six months ended July 31, 2013, compared with $26.1 million in the previous corresponding period.
Sales revenue rose 3.1 per cent to $1.46 billion.
Sigma says it continues to operate in a challenging environment but will look to the new Federal Government to provide greater certainty in the sector.
The group declared an interim dividend of two cents per share, fully franked.
- Forums
- ASX - By Stock
- SIP
- News: Sigma posts profit, despite challenges
News: Sigma posts profit, despite challenges
Featured News
Add SIP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online